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Brain injury and neurogenesis after intracerebral haemorrhage in hypertensive rats
YH Sang, RTF Cheung
Department of Medicine, The University of Hong Kong, Hong Kong
Introduction: Effective treatments for intracerebral haemorrhage (ICH) are awaited to reduce its morbidity and 
mortality. Hypertension is the most important risk factor for ICH. Neurogenesis following ICH in nomotensive 
rats has been confirmed. In this study, we used a rat renovascular hypertension (RVHT) model, and investigated 
the effects of hypertension on the pathophysiological and histological changes, and neural stem cell 
proliferation after induction of ICH. 
Methods: RVHT was achieved by applying a silver clip onto the left renal artery. At 6 weeks after renal artery 
constriction, the mRNA levels of angiogensin II type 1 (AT1) and type 2 (AT2) receptors in the brain were 
determined by reverse transcription–polymerase chain reaction. ICH was induced by an intrastriatal injection 
of bacterial collagenase IV in the left brain in both normotensive and hypertensive rats. Left femoral artery was 
cannulated for continuous monitoring of blood pressure for 4 hours after the induction of ICH. Haematoma 
volume was quantified at 24 hours after ICH induction. 5’-Bromo-2’-deoxyuridine (BrdU) was used to label cell 
proliferation from the 6th day to the 9th day after ICH. Rats were killed at 10 days after ICH. BrdU+ and CD31 
(an endothelial cell marker) immunoreactive cells were detected using immunofluorescence. Behavioural tests 
were performed at 1, 3, 7, 10, and 21 days after ICH. 
Results: RVHT rats showed up-regulation of AT1 receptor in the brain. Following induction of ICH, both the 
normotensive and RVHT rats demonstrated an acute hypertensive response. As compared to normotensive 
rats, RVHT rats demonstrated a larger haematoma volume, and greater deficits at all time-points. However, at 10 
days after ICH, more BrdU+ cells were detected over the perihaematoma area of RVHT rats than normotensive 
rats. Moreover, many BrdU+ cells within the ipsilateral basal ganglia of RVHT rats also co-expressed CD31. 
Conclusion: Renovascular hypertension aggravates histological and functional injury partly via up-regulation 
of AT1 receptor in the brain. Increased brain injury in hypertensive rats induces increased neural stem cell 
proliferation and angiogenesis after ICH. Experimental ICH in hypertensive rats is a suitable model for 
evaluation of pathophysiology and treatment of patients with hypertensive ICH.
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90Non-invasive cryolipolysis for body contouring in Chinese patients—the first clinical experience 
SYN Shek, CK Yeung, SGY Ho, NPY Chan, HH Chan
Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong
Background: The objective of this study was to determine the patient satisfaction and clinical efficacy of a novel 
cryolipolysis device (Zeltiq) for body contouring in Chinese patients.
Methods: Twenty-two patients with ‘discrete bulges’ were recruited for this procedure. All patients received one 
single treatment using the Zeltiq Breeze System using treatment parameters of CIF 41.6 (-73 milliwatts/cm2) for 
60 minutes at the desired anatomical region. The areas treated were flank, back, and abdomen. At baseline visit, 
their weight was measured and caliper measurement was taken at the maximum area of fat when standing. 
Standardised 3D photographs were taken with the Vectra Canfield System. They were followed up 2 months 
after the treatment and were assessed by the physician. Thereafter, they had their weight, subcutaneous 
fat measured by caliper and photographs taken. Subjective assessments were evaluated by means of a 
questionnaire. Any adverse effects were documented.
Results: The preliminary data generated by 21 follow-ups all reported that the treatment was tolerable. Objective 
assessment by caliper showed a statistically significant improvement as compared with control (P=0.001). 
Physician assessment showed good to very good improvement in 17 (81%) out of 21 subjects. Thirteen of them 
thought the treatment length was just right and eight thought it was too long. 70% of the subjects felt satisfied 
to very satisfied. Of 21 subjects, 17 (81%) reported noticeable difference in the area treated. Eighteen of them 
would recommend the treatment to family and friends, while three of them were unsure. 
Conclusion: For patients desiring a localised fat layer reduction, cryolipolysis offers a non-invasive, no-downtime 
procedure with high patient satisfaction and clinical efficacy.
